30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Margie McGlynn

Track

Insider profile

Currently holds positions in Air Products and Chemicals Inc, Amicus Therapeutics Inc and Vertex Pharmaceuticals Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 9% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Air Products and Chemicals Inc March 17, 2005 -
Independent Director Amicus Therapeutics Inc Oct. 1, 2009 -
Independent Director Vertex Pharmaceuticals Inc May 1, 2011 -
Margie McGlynn's trades of Amicus Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-06 2024-03-05
S Sale
15,566 +6.4%
65.95
US$1,284,958 		15,566 +6.4% 65.95 US$1,284,958
2024-03-05 2024-03-05
PrS Proposed sale
12,274
450.80
US$364,860 		12,274 450.80 US$364,860
2024-03-06 2024-03-04
S Sale
47,388 +42.3%
48.95
US$1,463,136 		47,388 +42.3% 48.95 US$1,463,136
2024-03-04 2024-03-04
PrS Proposed sale
7,500
13.29
US$99,675 		7,500 13.29 US$99,675
2023-01-17 2023-01-13
PlS Planned sale
15,000 -22.8%
13.03
US$195,387 		15,000 -22.8% 13.03 US$195,387
2022-05-04 2022-05-02
PlS Planned sale
15,000 -28.3%
6.99
US$104,896 		15,000 -28.3% 6.99 US$104,896
2022-04-12 2022-04-08
PlS Planned sale
100 -8.3%
281.49
US$28,149 		100 -8.3% 281.49 US$28,149
2022-04-12 2022-04-08
PlS Planned sale
4,900 -80.3%
280.19
US$1,372,931 		4,900 -80.3% 280.19 US$1,372,931
2022-04-04 2022-03-31
PlS Planned sale
1,011 -47.9%
262.97
US$265,863 		1,011 -47.9% 262.97 US$265,863
2022-04-04 2022-03-31
PlS Planned sale
2,970 -58.5%
262.37
US$779,239 		2,970 -58.5% 262.37 US$779,239
2022-04-04 2022-03-31
PlS Planned sale
1,019 -16.7%
261.28
US$266,244 		1,019 -16.7% 261.28 US$266,244
2022-02-01 2022-01-28
PlS Planned sale
212 -16.2%
243.24
US$51,567 		212 -16.2% 243.24 US$51,567
2022-02-01 2022-01-28
PlS Planned sale
2,087 -61.4%
242.78
US$506,682 		2,087 -61.4% 242.78 US$506,682
2022-02-01 2022-01-28
PlS Planned sale
800 -19.1%
241.83
US$193,464 		800 -19.1% 241.83 US$193,464
2022-02-01 2022-01-28
PlS Planned sale
1,901 -31.2%
240.53
US$457,248 		1,901 -31.2% 240.53 US$457,248
2020-04-20 2020-04-17
PlS Planned sale
10,000 -31.2%
11.00
US$110,000 		10,000 -31.2% 11.00 US$110,000
2020-01-10 2020-01-09
PlS Planned sale
20,000 -47.5%
10.00
US$200,000 		20,000 -47.5% 10.00 US$200,000
2019-10-24 2019-10-22
PlS Planned sale
20,000 -82.9%
190.00
US$3,800,000 		20,000 -82.9% 190.00 US$3,800,000
2004-02-04 2004-02-03
B Purchase
2,500 +55.6%
48.00
US$120,000 		2,500 +55.6% 48.00 US$120,000